Barnes & Thornburg LLP and Pearl IRB host a special event focused on the regulatory aspects of clinical research Sign up now FEATURED PRESENTATIONS: “Clinical trial site requirements for IRBs,” Michael Noone, Clinical Research Consultant and President of Circle...
We are proud to be featured in such a nationally recognized publication as CenterWatch. See below for an exerpt from the August 31, 2010 CW Weekly publication. “Indiana now has its first commercial Institutional Review Board (IRB). Indiana and its...
Pearl IRB was featured in the August 21st weekly print publication and on the web. See below for an excerpt: “Before the first volunteer takes a needle in the arm to test an experimental drug, the proposed clinical trial must first be vetted by a panel of...
Pearl IRB’s own Gretchen Bowker, Chief Operating Officer, will present an overview of the requirements and regulations surrounding IRB reviews on September 23, 2010. The meeting will be held over dinner at University of Indianapolis, 5:30-8pm. To sign up,...
Pearl IRB is pleased to launch it’s whitepaper entitled “Trends and Insights in IRB Warning Letters.” Learn all about IRB warning letters issued by the FDA, review the issues, and learn how to protect yourself from violations. Click here to...
Page 5 of 6« First«...23456»
